Familial breast cancer in southern Finlandhow prevalent are breast cancer families and can we trust the family history reported by patients?

European Journal of Cancer

Volumn 36, Issue 9, 2000, Pages 1143-1148

  Eerola, H ^a   Blomqvist, C ^a,b   Pukkala, E ^c   Pyrhonen S ^d   Nevanlinna, H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c FINNISH CANCER REGISTRY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast neoplasm; Familial; Genetics

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER SUSCEPTIBILITY; FAMILY HISTORY; FEMALE; FINLAND; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RELATIVE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FINLAND; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0034085969     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00093-9     Document Type: Article

References (33)

1. Finnish Cancer Registry. Cancer Incidence in Finland 1995. Cancer Statistics of the National Research and Development Centre for Welfare and Health. Helsinki, Cancer Society of Finland, 1997, Publication No. 58.
2. Madigan M.P., Ziegler R.G., Benichou J., Byrne C., Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl. Cancer Inst. 87:1995;1681-1685.
3. Dupont W.D., Page D.L. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am. J. Epidemiol. 125:1987;769-779.
4. Claus E.B., Risch N.J., Thompson W.D. Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131:1990;961-972.
5. Tulinius H., Sigvaldason H., Olafsdottir G.H., Tryggvadottir L. Epidemiology of breast cancer in families in Iceland. J. Med. Genet. 29:1992;158-164.
6. Houlston R.S., McCarter E., Parbhoo S., Scurr J.H., Slack J. Family history and risk of breast cancer. J. Med. Genet. 29:1992;154-157.
7. Claus E.B., Risch N., Thompson D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48:1991;232-242.
8. Newman B., Austin M.A., Lee M., King M. Inheritance of human breast cancer, evidence for autosomal dominant transmission in high risk families. Proc. Natl. Acad. Sci. 85:1988;3044-3048.
9. Schildkraut J., Risch N., Thompson W. Evaluating genetic association among ovarian, breast and endometrial cancer, evidence for a breast/ovarian cancer relationship. Am. J. Hum. Genet. 45:1989;521-529.
10. Narod S.A., Madlensky L., Bradley L.et al. Hereditary and familial ovarian cancer in Southern Ontario. Cancer. 74:1994;2341-2346.
11. Claus E.B., Schildkraut J.M., Thompson W.D., Risch N.J. The genetic attributable risk of breast and ovarian cancer. Cancer. 77:1996;2318-2324.
12. Miki Y., Swensen J., Shattuck-Eidens D.et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
13. Wooster R., Bignell G., Lancaster J.et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
14. Ford D., Easton D.F., Stratton M.et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62:1998;676-689.
15. Love R.R., Evans A.M., Josten D.M. The accuracy of patients reports of a family history of cancer. J. Chron. Dis. 38:1985;289-293.
16. Theis B., Boyd N., Lockwood G., Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur. J. Cancer Prev. 3:1994;321-327.
17. Douglas F.S., O'Dair L.C., Robinsson M., Evans D.G.R., Lynch S.A. The accuracy of diagnoses as reported in families with cancer, a retrospective study. J. Med. Genet. 36:1999;309-312.
18. Gladstone A., Adatto P., Cunningham J.et al. Family history of cancer in patients with glioma, a validation study of accuracy. J. Natl. Cancer Inst. 90:1998;543-544.
19. Koch M., Gaedke H., Jenkins H. Family history of ovarian cancer patients, a case-control study. Int. J. Epidemiol. 18:1989;782-785.
20. Kerber R.A., Slattery M.L. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am. J. Epidemiol. 146:1997;244-248.
21. Kerr B., Foulkes W.D., Cade D.et al. False family history of breast cancer in the family cancer clinic. Eur. J. Surg. Oncol. 24:1998;275-279.
22. Teppo L., Pukkala E., Lehtonen M. Data quality and quality control of a population-based cancer registry. Acta Oncol. 33:1994;365-369.
23. Lynch H.T., Watson P., Conway T., Fitzsimmons M.L., Lynch J. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res. and Treat. 11:1988;263-267.
24. Thompson W.D. Genetic epidemiology of breast cancer. Cancer. 74:1994;279-287.
25. Peto J., Collins N., Barfoot R., Seal S.et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl. Cancer Inst. 91:1999;943-949.
26. Hopper J., Southney M., Dite G.et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol., Biomarkers and Prev. 8:1999;741-747.
27. Thorlacius S., Struewing J., Hartge P.et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutations. Lancet. 352:1998;1337-1339.
28. Warner E., Foulkes W., Goodwin P. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J. Natl. Cancer Inst. 91:1999;1241-1247.
29. Vasen H.F.A., Haites N.E., Evans D.G.R.et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer, a survey among 16 European family cancer clinics. Eur. J. Cancer. 34:1998;1922-1926.
30. Parmigiani G., Berry D.A., Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet. 62:1998;145-158.
31. Serova O.M., Mazoyer S., Puget N.et al. Mutations in BRCA1 and BRCA2 in breast cancer families, are there more breast cancer-susceptibility genes? Am. J. Hum. Genet. 60:1997;486-495.
32. Vehmanen P., Friedman L.S., Eerola H.et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families, evidence for additional susceptibility genes. Hum. Mol. Genet. 6:1997;2309.
33. Schubert E.L., Lee M.K., Mefford H.C.et al. BRCA2 in American families with four or more cases of breast or ovarian cancer, recurrent and novel mutations, variable expression, penetrance, and possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am. J. Hum. Genet. 60:1997;1031-1040.